Medtronic plc (NYSE:MDT) traded at $108.15 at last check on Wednesday, Sep 16, making an upward move of 0.54% on its previous day’s price.

Looking at the stock we see that its previous close was $107.57 and the beta (5Y monthly) reads 0.67 with the day’s price range being $107.38 – 108.43. The company has a 12-month trailing PE ratio of 33.19. In terms of its 52-week price range, MDT has a high of $122.15 and a low of $72.13. The company’s stock has gained about 6.81% over that past 30 days.

Medtronic has a market cap of $144.61 Billion and is expected to release its quarterly earnings report on November 24, 2020. With its Forward Dividend at 2.32 and a yield of 2.16%, the company’s investors could be anxious for the MDT stock to gain ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $0.83, with the EPS growth for the year declined at $4.04 for 2020 and $5.78 for next year. These figures represent -0.12% and at 0.43% growth in EPS for the two years respectively.

On the other hand, looking at the outlook for the MDT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Buy.

Based on estimates by 26 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 6 have rated the Medtronic plc (MDT) stock as a Hold, while 18 rate it as a Buy. 2 analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.

Looking further, we note that the PEG ratio for the MDT stock currently stands at 3.53, and the current price level is 3.3% off its SMA20 and 8.17% from its 50-day simple moving average. The RSI (14) is pointing at 63.88 while the volatility over the past week is 1.93% and jumps to 2.04% over the past one month. The beta value is 0.67, while the average true range (ATR) is currently pointing at 2.3. The average price target for the stock over the next 12 months is $117.73, with the estimates having a low of $110 and a high of $130. These price ends are 1.71% and +20.2% off the current price level respectively, although investors could be excited at the prospect of a +9.11% if the MDT share price touches on the median price of $118.

Let’s briefly compare Medtronic (MDT) stock to its peers. We find that today’s price change of +0.54% and -1.36% over the past 12 months for MDT competes that of Abbott Laboratories (ABT), which has seen its stock price rise 0.31% in the latest trading session and is +27.86% over the last one year. Another of its peers Stryker Corp (SYK) has climbed 2.05% today, but is -2.22% down over the past year, while Boston Scientific Corp (BSX) is also up 0.54% yet its price remains in the red at -1.36% over the same period. Abbott has a P/E ratio of 61.64 compared to Medtronic’s 33.19 and Stryker’s 50. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.56% and 0.78%, respectively, in early deals.

Coming back to Medtronic plc (NYSE:MDT), we note that the average 3-month trading volume was 4.91 Million, while that of the preceding 10-day period stands at 4.13 Million. Current shares outstanding are 1.34 Billion.

According to data from Thomson Reuters, insiders hold 0.07% of the company’s shares while institutions hold 85.82%. The data shows that short shares as of August 30, 2020, stood at 7.29 Million at a short ratio of 1.53. This represents a 0.54% Short interest in Shares outstanding on August 30, 2020. Shares short dropped in August from the previous month at 7.8 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -5.18% down in year-to-date price movement.